AI brief of an SEC Form 8-K · Bruker (BRKR)

Bruker Q2 revenue rises 5.2% to $838.5M; $134.9M impairment drives GAAP loss

Mixed Impact 3 of 5 earnings Written later

Bruker reported second-quarter 2026 revenue of $838.5 million, up 5.2% year over year, and non-GAAP diluted EPS of $0.49, up from $0.32. A $134.9 million goodwill impairment produced a GAAP diluted loss of $(0.41) per share, and FY26 non-GAAP EPS guidance of $2.10 to $2.15 was kept, with the outlook updated only for currency and tax.

Key points

  • Q2 revenue of $838.5 million, up 5.2%; organic growth was 2.8%, or 3.4% excluding tariff refunds
  • GAAP diluted loss of $(0.41) per share versus $0.05 a year earlier, including a $134.9 million goodwill impairment charge
  • Non-GAAP diluted EPS of $0.49 versus $0.32; non-GAAP operating margin of 14.1% versus 9.0%
  • FY26 non-GAAP EPS guidance of $2.10 to $2.15 unchanged; currency tailwind to revenue cut to approximately 0.5% from 1.5%

The filing

CompanyBruker (BRKR)
Form8-K, current report
Filed with the SECAug 4, 2026, 7:00 AM ET
Accession number0001193125-26-331511

Items reported: 2.02 Results of Operations

Read the filing on SEC.gov ↗

Written by AI on Nov 8, 2026, 1:17 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on August 04, 2026.

Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.